- Home
- ABEO vs RMNI Comparison
ABEO vs RMNI Comparison
Compare ABEO & RMNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- RMNI
- Stock Information
- Founded
- ABEO 1974
- RMNI 2005
- Country
- ABEO United States
- RMNI United States
- Employees
- ABEO N/A
- RMNI N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- RMNI Business Services
- Sector
- ABEO Health Care
- RMNI Consumer Discretionary
- Exchange
- ABEO Nasdaq
- RMNI Nasdaq
- Market Cap
- ABEO 332.0M
- RMNI 368.8M
- IPO Year
- ABEO 1980
- RMNI N/A
- Fundamental
- Price
- ABEO $6.26
- RMNI $4.02
- Analyst Decision
- ABEO Strong Buy
- RMNI Strong Buy
- Analyst Count
- ABEO 6
- RMNI 1
- Target Price
- ABEO $18.00
- RMNI $6.00
- AVG Volume (30 Days)
- ABEO 611.9K
- RMNI 401.7K
- Earning Date
- ABEO 08-19-2025
- RMNI 07-31-2025
- Dividend Yield
- ABEO N/A
- RMNI N/A
- EPS Growth
- ABEO N/A
- RMNI N/A
- EPS
- ABEO N/A
- RMNI N/A
- Revenue
- ABEO N/A
- RMNI $427,203,000.00
- Revenue This Year
- ABEO N/A
- RMNI $1.38
- Revenue Next Year
- ABEO $322.37
- RMNI $3.97
- P/E Ratio
- ABEO N/A
- RMNI N/A
- Revenue Growth
- ABEO N/A
- RMNI N/A
- 52 Week Low
- ABEO $3.93
- RMNI $1.53
- 52 Week High
- ABEO $7.32
- RMNI $5.38
- Technical
- Relative Strength Index (RSI)
- ABEO 47.50
- RMNI 42.04
- Support Level
- ABEO $6.18
- RMNI $3.92
- Resistance Level
- ABEO $6.94
- RMNI $4.08
- Average True Range (ATR)
- ABEO 0.27
- RMNI 0.20
- MACD
- ABEO -0.05
- RMNI -0.13
- Stochastic Oscillator
- ABEO 18.07
- RMNI 11.22
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
About RMNI Rimini Street Inc. (DE)
Rimini Street Inc and its subsidiaries are providers of end-to-end enterprise software support, products, and services. The Company offers a comprehensive family of unified solutions to run, manage, support, customize, configure, connect, protect, monitor, and optimize clients' enterprise applications, database, and technology software platforms. The Company derives revenues from clients by providing subscription support services for enterprise resource planning, customer relationship management, product lifecycle management database, and technology software systems. Geographically, the company generates the majority of its revenue from the United States of America and the International market.